RESUMO
Expression of the RCAN1 gene can be induced by multiple stresses. RCAN1 proteins (RCAN1s) have both protective and harmful effects and are implicated in common human pathologies. The mechanisms by which RCAN1s function, however, remain poorly understood. We identify RCAN1s as regulators of mitochondrial autophagy (mitophagy) and demonstrate that induction of RCAN1-1L can cause dramatic degradation of mitochondria. The mechanisms of such degradation involve the adenine nucleotide translocator and mitochondrial permeability transition pore opening. We also demonstrate that RCAN1-1L induction can shift cellular bioenergetics from aerobic respiration to glycolysis, yet RCAN1-1L has very little effect on cell division, whereas it has a cumulative negative effect on cell survival. These results shed the light on mechanisms by which RCAN1s can protect or harm cells and by which they may operate in human pathologies. They also suggest that RCAN1s are important players in autophagy and such elusive phenomena as the mitochondrial permeability transition pore.
Assuntos
Regulação Enzimológica da Expressão Gênica , Peptídeos e Proteínas de Sinalização Intracelular/metabolismo , Proteínas Musculares/biossíntese , Oxigênio/metabolismo , Translocador 1 do Nucleotídeo Adenina/metabolismo , Animais , Autofagia , Morte Celular , Separação Celular , Sobrevivência Celular , Proteínas de Ligação a DNA , Citometria de Fluxo , Glicólise , Microscopia Eletrônica de Transmissão/métodos , Estresse Oxidativo , Fosforilação , RatosRESUMO
Primary cilia are present on mammalian neurons and glia, but their function is largely unknown. We generated conditional homozygous mutant mice for a gene we termed Stumpy. Mutants lack cilia and have conspicuous abnormalities in postnatally developing brain regions, including a hypoplasic hippocampus characterized by a primary deficiency in neural stem cells known as astrocyte-like neural precursors (ALNPs). Previous studies suggested that primary cilia mediate sonic hedgehog (Shh) signaling. Here, we find that loss of ALNP cilia leads to abrogated Shh activity, increased cell cycle exit, and morphological abnormalities in ALNPs. Processing of Gli3, a mediator of Shh signaling, is also altered in the absence of cilia. Further, key mediators of the Shh pathway localize to ALNP cilia. Thus, selective targeting of Shh machinery to primary cilia confers to ALNPs the ability to differentially respond to Shh mitogenic signals compared to neighboring cells. Our data suggest these organelles are cellular "antennae" critically required to modulate ALNP behavior.
Assuntos
Diferenciação Celular , Cílios/metabolismo , Proteínas Hedgehog/metabolismo , Hipocampo/embriologia , Neurônios/citologia , Transdução de Sinais , Animais , Animais Recém-Nascidos , Astrócitos/citologia , Astrócitos/ultraestrutura , Ciclo Celular , Proliferação de Células , Cílios/ultraestrutura , Regulação da Expressão Gênica no Desenvolvimento , Proteínas Hedgehog/genética , Hipocampo/anormalidades , Fatores de Transcrição Kruppel-Like/metabolismo , Camundongos , Mutação/genética , Proteínas do Tecido Nervoso/metabolismo , Neurônios/ultraestrutura , Transporte Proteico , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Células-Tronco/citologia , Proteína Gli3 com Dedos de ZincoRESUMO
Synchrotron X-ray sources provide the highest quality crystallographic data for structure-guided drug design. In general, industrial utilization of such sources has been intermittent and occasionally limited. The Lilly Research Laboratories Collaborative Access Team (LRL-CAT) beamline provides a unique alternative to traditional synchrotron use by pharmaceutical and biotechnology companies. Crystallographic experiments at LRL-CAT and the results therefrom are integrated directly into the drug discovery process, permitting structural data, including screening of fragment libraries, to be routinely and rapidly used on a daily basis as part of pharmaceutical lead discovery and optimization. Here we describe how LRL-CAT acquires and disseminates the results from protein crystallography to maximize their impact on the development of new potential medicines.